BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21325372)

  • 1. Epigenetics of thyroid cancer and novel therapeutic targets.
    Russo D; Damante G; Puxeddu E; Durante C; Filetti S
    J Mol Endocrinol; 2011 Jun; 46(3):R73-81. PubMed ID: 21325372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging molecular therapies of advanced thyroid cancer.
    Catalano MG; Poli R; Pugliese M; Fortunati N; Boccuzzi G
    Mol Aspects Med; 2010 Apr; 31(2):215-26. PubMed ID: 20176050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting histone deacetylase in thyroid cancer.
    Russo D; Durante C; Bulotta S; Puppin C; Puxeddu E; Filetti S; Damante G
    Expert Opin Ther Targets; 2013 Feb; 17(2):179-93. PubMed ID: 23234477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic dysregulation in thyroid neoplasia.
    Kondo T; Asa SL; Ezzat S
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
    Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
    Li LC; Carroll PR; Dahiya R
    J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics and cancer treatment.
    Kristensen LS; Nielsen HM; Hansen LL
    Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of disease: epigenesis.
    Waggoner D
    Semin Pediatr Neurol; 2007 Mar; 14(1):7-14. PubMed ID: 17331879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epigenetics of oral cancer.
    Shaw R
    Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer.
    Shinjo K; Kondo Y
    Methods Mol Biol; 2012; 863():221-39. PubMed ID: 22359296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
    Takai N; Kawamata N; Walsh CS; Gery S; Desmond JC; Whittaker S; Said JW; Popoviciu LM; Jones PA; Miyakawa I; Koeffler HP
    Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation as a regulatory mechanism for gene expression in mammals.
    Serman A; Vlahović M; Serman L; Bulić-Jakus F
    Coll Antropol; 2006 Sep; 30(3):665-71. PubMed ID: 17058541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.